WASHINGTON, DC—New data from the PARTNER 3 low-risk trial of patients with symptomatic, severe aortic stenosis show that TAVI ...
In the diverse cohort, risks were particularly amplified in Black Americans, likely due to structural and environmental factors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results